Sanja Vukadinovic Stojanovic, Zlatan Stojanovic, Gordana Macanovic, Nada Banjac, Zelimir Eric


Introduction and Aim: Depression in psychiatry covers a large area of mental pathology and it is one of the most complex problems of modern medicine with broad implications for the health of the individual and the society as a whole. Depression is also a frequent companion of alcohol addiction. The aim of this study was to investigate the effect of the antidepressant drug sertaline on the lenght of QT interval in depressed patients with alcohol dependence. Patients and methods: This research included male patients (older than 18 years of age) suffering from alcohol addiction, who were also diagnosed with depression, that is, depressive disorder,at the beginnig of hospitalisation, on the basis of DSM-IV (Diagnostic and statistical manual of mental disorders) criterion and positive Hamilton Rating Scale for Depression (HRSD). The study included 49 patients treated wit antidepressant sertaline for 20 days. In our study, the global QTc interval (12 leads) was determined automatically by applying ECG device of the producer and type "Schiller Cardiovit AT-1"which uses "SCHILLER  ECG Measurement and Interpretation Software for Children and Adults ECGs". Measured empirical values of data were statistically processed in SPSS 16.0 programme package for Windows. Methods of descriptive statistics and methods of statistic testing of hypotheses were used. Results: In our study, in spite of the vulnerability of patients due to the heart damage and the lyver dysfunction arising from alcohol consumption, as well as altered patients drugs metabolism, no elongation of QTc interval resulting from the application of sertaline was established (p=0.735). The average prolongation of QTc interval of 1.633 ms was observed (95% CI =8.005 ms, 11.270 ms). Conclusion:Our study does not indicate that the antidepressant drug sertaline has a statistically significant effect on the prolongation of the QT interval of depressed patients with alcohol dependence.


alcohol addiction, depression, comorbidity, QT interval, sertaline

Full Text:



Grant BF, Harford TC. Comorbidity between DSM-IV alcohol use

disorders and major depression: results of a national survey. Drug

Alcohol Depend. 1995; 39(3): 197-206.

American Psychiatric Association.Diagnostic and statistical manual of mental disorders. 4th ed. Washington DC: American Psychiatric Association, 2000.

Hamilton M. A rating scale for depression. J Neurol Neurosurg Pasychiatry. 1960;23(1):56-62.

Lanjewar P, Pathak V, Lokhandwala Y. Issues in QT interval measurement. Indian Pacing Electophysiol J. 2004;4(4):156-61.

Hosmane B, Locke C, Morris D. QT interval:correction for heart rate.J Appl Res.2006;6(4):288-99.

Lokhandwala Y, Toal SC. The fallacies of QT correction. Indian Pacing Elecrophysiol J.2003; 3(4):185-6.

Pickham D, Hasanien AA. Measurement and the rate correction of the QT interval. AACN Adv Crit Care.2013;24(1):90-6.

Kligfield P, Tyl B, Maarek M, Maison-Blanche P. Magnitude, mechanism, and reproducibility of QT interval differences between superimposed global and individual lead ECG complexes. Ann Noninvasive Electocardiol.2007;12(2)145-52.

Sicouri S, Antzelevitch C. Sudden cardiac death secondary to antidepressant and antipsychotic drugs. Expert Opin Drug Saf.2008;7(2):181-94.

Goodnick PJ, Jerry J, Parra F. Psychotropic drugs and the ECG:focus on teh QTc interval. Expert Opin Pharmacother.2002;3(5):479-98.

Wenzel-Seifert K, Wittmann M, Haen E. QTc prolongation by psychotropic drugs and the risk of Torsade de Pointes. Dtsch Arztebl Int.2011;108(41):687-93.

Okayasu H, Ozeki Y, Fuji K, Takano Y, Saeki Y, Hori H et al.Pharmacotherapeutic determinants for QTc interval prolongation in Japanese patients with mood disorder. Pharmacopsychiatry.2012;45(7):279-83.

Sala M, Vicentini A, Brambilla P, Montomoli C, Jogia JR, Caverzasi E, et al. QT interval prolongation related to psychoactive drug treatment:a comparison of monotherapy versus polytherapy. Ann Gen Psychiatry.2005;4(1):1.

Waring WS, Graham A, Gray J, Wilson AD, Howell C, Bateman DN. Evaluation of a QT nomogram for risk assessment after antidepressant overdose. Br J Clin Pharmacol.2010;70(6):881-85.

Patane S, Marte F, Di Bella G. QT interval prolongation and torsade de pointes. Int J Cardiol.2009;131(2):51-3.

Boer RA, Dijk TH, Holman ND, Melle JP. QT interval prolongation after sertaline overdose: a case report. BMC Emerg Med.2005;5:5.

Hoehns JD, Fouts MM, Kelly MW, Tu KB. Sudden cardiac death with clozapine and sertaline combination. Ann Pharmacother. 2001; 35(7-8); 862-66.

Barbey JT, Roose SP. SSRI safety in overdose. J Clin Psychiatry.1998; 59(suppl 15):42-8.

Alderman J. Coadministration of sertaline with cisapride or pimozide:an open-label, nonrandomized examination of pharmacokinetics and corrected QT inrevals in healthy adult volunteers. Clin Ther.2005;27(7):1050-63.

Beach SR, Celano CM, Noseworthy PA, Januzzi JL, Huffman JC. QTc prolongation, tosades des pointes and psychotropic medications. Psychosomatics.2013;54(1)1-13.



  • There are currently no refbacks.

Copyright (c) 2019 Zlatan Stojanovic

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.